Scott J Charles Insider Trading $ARLZ Old API Wind-down Ltd.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Scott J Charles.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Scott J Charles. Scott J Charles is Vice President of Finance in POZEN INC /NC ($POZN) and Chief Financial Officer in Aralez Pharmaceuticals Inc. ($ARLZ).
Scott J Charles in Old API Wind-down Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Scott J Charles: Chief Financial Officer
Holdings: 280,551 shares
Current Value: $1,175,509
Latest Transaction: Jul 28 2017
$ARLZ Market Capitalization: $270.87M
$ARLZ Previous Close: $4.19
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Scott J Charles in Old API Wind-down Ltd.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 28 2017 | ARLZ | Aralez Pharmaceuti ... | Charles Scott J | Chief Financial Off ... | Sell | S | 1.25 | 10,804 | 13,509 | 280,551 | 291.4 K to 280.6 K (-3.71 %) |
| Jul 28 2017 | ARLZ | Aralez Pharmaceuti ... | Charles Scott J | Chief Financial Off ... | Sell | S | 1.25 | 10,804 | 13,509 | 280,551 | 291.4 K to 280.6 K (-3.71 %) |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Charles Scott J | Chief Financial Off ... | Option Exercise | A | 1.56 | 96,121 | 149,949 | 96,121 | |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Charles Scott J | Chief Financial Off ... | Grant | A | 0.00 | 83,192 | 0 | 291,355 | 208.2 K to 291.4 K (+39.96 %) |
| Mar 22 2017 | ARLZ | Aralez Pharmaceuti ... | Charles Scott J | Chief Financial Off ... | Sell | S | 2.41 | 5,205 | 12,544 | 208,163 | 213.4 K to 208.2 K (-2.44 %) |
| May 16 2016 | ARLZ | Aralez Pharmaceuti ... | Charles Scott J | Chief Financial Off ... | Buy | P | 3.49 | 50,000 | 174,495 | 213,368 | 163.4 K to 213.4 K (+30.61 %) |
| Mar 18 2016 | ARLZ | Aralez Pharmaceuti ... | Charles Scott J | Chief Financial Off ... | Option Exercise | A | 3.80 | 40,096 | 152,365 | 40,096 | |
| Mar 18 2016 | ARLZ | Aralez Pharmaceuti ... | Charles Scott J | Chief Financial Off ... | Grant | A | 0.00 | 47,368 | 0 | 163,368 | 116 K to 163.4 K (+40.83 %) |
| Feb 17 2016 | ARLZ | Aralez Pharmaceuti ... | Charles Scott J | Chief Financial Off ... | Grant | A | 0.00 | 86,863 | 0 | 116,000 | 29.1 K to 116 K (+298.12 %) |
| Feb 09 2016 | ARLZ | Aralez Pharmaceuti ... | Charles Scott J | Chief Financial Off ... | Buy | J | 0.00 | 29,137 | 0 | 29,137 | 0 to 29.1 K |
Page: 1